37. CCoonncclluussiioonnii
1. La riabilitazione è più efficace dell’osservazione
2. Dovrebbe iniziare al più presto possibile
3. I-PDE5 possono essere usati con successo nei pazienti sottoposti a RP NS
4. Altri trattamenti (FIC, Vacuum…) possono essere associati o utilizzati,
soprattutto in caso di inefficacia degli I-PDE5
38. CCoonncclluussiioonnii
1. Scarsa evidenza per supportare veri e propri protocolli riabilitativi
2. Specifici trattamenti non possono essere raccomandati
3. La riabilitazione dovrebbe essere pianificata in dosi e combinazioni variabili,
considerando i desideri e le aspettative del paziente
4. Questi trattamenti dovrebbero essere somministrati al più presto
5. Attenzione a non enfatizzare troppo il ruolo della riabilitazione nel recupero
dell’attività erettiva
39. Questa presentazione è disponibile sul sito I AM - Interact around Man - la
community degli specialisti della salute dell’uomo: www.esanum.it/iam.
powered by
40. Tu sei libero di:
condividere — riprodurre, distribuire, comunicare al pubblico, esporre in pubblico, rappresentare,
eseguire e recitare questo materiale con qualsiasi mezzo e formato;
modificare — remixare, trasformare il materiale e basarti su di esso per le tue opere.
Ai seguenti termini:
1)Attribution — Devi attribuire adeguatamente la paternità sul materiale, fornire un link alla licenza e
indicare se sono state effettuate modifiche. Puoi realizzare questi termini in qualsiasi maniera
ragionevolmente possibile, ma non in modo tale da suggerire che il licenziante avalli te o il modo in cui usi
il materiale;
2)NonCommercial — Non puoi usare il materiale per scopi commerciali;
3)ShareAlike — Se remixi, trasformi il materiale o ti basi su di esso, devi distribuire i tuoi contributi con la
stessa licenza del materiale originario.
I termini completi della licenza sono disponibili qui: http://creativecommons.org/licenses/by-nc-sa/4.0/deed.it
Editor's Notes
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.
Permixon is one of the medical treatment of uncomplicated, symptomatic BPH most widely used. It is an hexane lipido-sterolic extract of Serenoa repens.
This part of the presentation will detail the outcomes of the investigation on this drug.